Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Dhruv Wellness's EBITDA for the
six
months ended in Sep. 2023 was ₹0.02 Mil. Dhruv Wellness's Revenue for the
six
months ended in Sep. 2023 was ₹1.90 Mil. Therefore, Dhruv Wellness's EBITDA margin for the quarter that ended in Sep. 2023 was 1.11%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Dhruv Wellness EBITDA Margin % Related Terms
Dhruv Wellness EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Dhruv Wellness's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:540695 vs MCK, COR, CAH: EBITDA Margin % Comparison
For the Medical Distribution subindustry, Dhruv Wellness's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dhruv Wellness EBITDA Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Dhruv Wellness's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Dhruv Wellness's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dhruv Wellness (BOM:540695) has a EBITDA Margin % of 1.11% as of Sep. 2023. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Dhruv Wellness and its competitors.
Is Dhruv Wellness' EBITDA Margin % too high?
Dhruv Wellness' current EBITDA Margin % is 1.11%. The Medical Distribution industry median EBITDA Margin % is 4.24. Dhruv Wellness' value of 1.11% is 73.8% below this industry median. Overall, Dhruv Wellness has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Dhruv Wellness' EBITDA Margin % compare to MCK and COR?
Dhruv Wellness' EBITDA Margin % of 1.11% can be compared against companies in the Medical Distribution industry. The industry median EBITDA Margin % is 4.24. Dhruv Wellness' value of 1.11% is 73.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Distribution company?
The median EBITDA Margin % among Medical Distribution companies is 4.24, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dhruv Wellness's current EBITDA Margin % of 1.11% is 73.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Dhruv Wellness and its competitors. For the Medical Distribution industry, the median EBITDA Margin % is 4.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dhruv Wellness's current EBITDA Margin % is 1.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dhruv Wellness stock overvalued right now?
Dhruv Wellness (BOM:540695) has a current EBITDA Margin % of 1.11%. The current EBITDA Margin % is 1.11% and 73.8% below the Medical Distribution industry median of 4.24. Dhruv Wellness' overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Dhruv Wellness (BOM:540695), the current EBITDA Margin % is 1.11% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Dhruv Wellness Ltd is engaged in the wholesale and distribution of general, ayurvedic, pharmaceutical, and cosmetic products. It operates as a stockist of medical, general cosmetics, and pharmaceutical products. Some of the company's products are Kesho Grow, Livopro, Musli Vita, Ortho Cure, and among others.
4GF Score
Get the complete analysis for BOM:540695
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540695 has been successfully added to your 
